In contrast to G protein-coupled receptors, for which chemical and peptidic inhibitors have been extensively explored, few compounds are available that directly modulate heterotrimeric G proteins. Active Gα binds its two major classes of effectors, the phospholipase C (PLC)-β isozymes and Rho guanine nucleotide exchange factors (RhoGEFs) related to Trio, in a strikingly similar fashion: a continuous helix-turn-helix of the effectors engages Gα within its canonical binding site consisting of a groove formed between switch II and helix α3. This information was exploited to synthesize peptides that bound active Gα in vitro with affinities similar to full-length effectors and directly competed with effectors for engagement of Gα A representative peptide was specific for active Gα because it did not bind inactive Gα or other classes of active Gα subunits and did not inhibit the activation of PLC-β3 by Gβγ In contrast, the peptide robustly prevented activation of PLC-β3 or p63RhoGEF by Gα; it also prevented G protein-coupled receptor-promoted neuronal depolarization downstream of Gα in the mouse prefrontal cortex. Moreover, a genetically encoded form of this peptide flanked by fluorescent proteins inhibited Gα-dependent activation of PLC-β3 at least as effectively as a dominant-negative form of full-length PLC-β3. These attributes suggest that related, cell-penetrating peptides should effectively inhibit active Gα in cells and that these and genetically encoded sequences may find application as molecular probes, drug leads, and biosensors to monitor the spatiotemporal activation of Gα in cells.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207258 | PMC |
http://dx.doi.org/10.1074/jbc.M116.740407 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!